Chronic diseases can no more be treated just like lifestyle diseases that can be looked after by medicines.Read more
Tag Archives: COVID-19
Being on the right side of manufacturing compliance is the key for Indian pharma companies. A complex product portfolio and cost effectiveness would matter too. But potential drug discoveries may have a joker-in-the-pack effect.Read more
Besides unlocking the value of intermediates, Mangalam Organics has been in the process of
improving the quality of camphor. The company has two retail brands—Mangalam and CamPure.
Some pharma companies are gearing up to achieve new-highs through intelligent selection of product portfolio, markets and marketing preferences. They are walking the tight-rope on cost management.Read more
COVID-19 might have affected good companies temporarily. But it has possibly opened the Pandora Box. You should carefully monitor Q2FY21 numbers of listed companies to know which companies are facing difficulties.Read more
Price performance of stocks post-earnings will tell you how close the results were to the market expectations. Unless companies that witnessed an impressive growth in Q4FY20 perform miserably and give a negative outlook, markets might prefer to look beyond Q2 and Q3 in their case.Read more